Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

Reducing Racial Disparities in Cancer Care With PINPOINT (Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy)

The purpose of the research is to: develop an educational website to empower Black and African American cancer patients to make informed decisions about personalized cancer treatment and clinical trials. The sample size for the qualitative interviews was (n=48) when saturation was achieved. With a goal of (n=33) for the pilot trial, the overall target sample size for the study is (n=81).

The website offers tools for discussing innovative treatments with their clinicians, finding clinical trials, and locating support groups. We are conducting key informant interviews, testing the website with pilot tester and asking volunteers from our Community Advisory Board to review our website prototype to further improve its design and features.

Inclusion Criteria

Patient Key Informant:

• Age 18 and older
• Self-identify as Black/African American
• Diagnosed with solid tumor
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Relative Key Informant:

• Age 18 and older
• Spouse, blood relative, or caregiver of a cancer patient who identifies as Black/African American
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Provider Key Informant:

• Age 18 and older
• Physician, nurse, social worker, patient navigator, or financial counselor
• Work in oncology setting
• Able to read and speak English fluently
• Able to provide informed consent
• Able to complete 1 survey and an in-depth interview

Pilot Tester:

• Age 18 and older
• Self-identify as Black/African American
• Able to read and speak English fluently
• Able to provide informed consent
• Newly diagnosed with solid tumor cancer (Stage I-IV)
• Have not yet consulted with an oncologist regarding treatment
• Able to complete 2 surveys and an in-depth interview

Exclusion Criteria

Key informants will be excluded from the study if they do not meet the inclusion criteria. Pilot testers will be excluded from the study if they previously participated as key informants and do not meet inclusion criteria.